Actavis to pay $202M in Medicaid overbilling settlements

Actavis has agreed to pay $118 million to settle claims that the U.S. government and four states overpaid for its drugs. The deal follows an $84 million settlement of similar claims filed by the state of Texas. Report

Suggested Articles

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections.

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.